\begin{table}[!htbp]
\centering
\begin{tabular}{lllllll}
  \hline
  & Chronic kidney disease & Chronic lung disease & Diabetes & Immunocompromised & None of the studied comorbidities & Overall \\ 
  \hline
 & (N=68896) & (N=140435) & (N=135915) & (N=158016) & (N=862335) & (N=1218630) \\ 
  Sex &  &  &  &  &  &  \\ 
    Female & 36626 (53.2\%) & 90915 (64.7\%) & 70883 (52.2\%) & 98047 (62.0\%) & 530797 (61.6\%) & 742950 (61.0\%) \\ 
    Male & 32270 (46.8\%) & 49520 (35.3\%) & 65032 (47.8\%) & 59969 (38.0\%) & 331538 (38.4\%) & 475680 (39.0\%) \\ 
  Race &  &  &  &  &  &  \\ 
    White & 52668 (76.4\%) & 110317 (78.6\%) & 95658 (70.4\%) & 128964 (81.6\%) & 600231 (69.6\%) & 873934 (71.7\%) \\ 
    Unknown & 2841 (4.1\%) & 8321 (5.9\%) & 10637 (7.8\%) & 8815 (5.6\%) & 136361 (15.8\%) & 160155 (13.1\%) \\ 
    Black or African American & 11103 (16.1\%) & 16713 (11.9\%) & 21446 (15.8\%) & 14630 (9.3\%) & 68329 (7.9\%) & 111002 (9.1\%) \\ 
    Asian & 1974 (2.9\%) & 3999 (2.8\%) & 7062 (5.2\%) & 4730 (3.0\%) & 52471 (6.1\%) & 66198 (5.4\%) \\ 
    American Indian or Alaska Native & 176 (0.3\%) & 750 (0.5\%) & 602 (0.4\%) & 581 (0.4\%) & 2717 (0.3\%) & 4184 (0.3\%) \\ 
    Native Hawaiian or Other Pacific Islander & 134 (0.2\%) & 335 (0.2\%) & 510 (0.4\%) & 296 (0.2\%) & 2226 (0.3\%) & 3157 (0.3\%) \\ 
  Ethnicity &  &  &  &  &  &  \\ 
    Not Hispanic or Latino & 64238 (93.2\%) & 128631 (91.6\%) & 119543 (88.0\%) & 146001 (92.4\%) & 696936 (80.8\%) & 1018823 (83.6\%) \\ 
    Hispanic or Latino & 3285 (4.8\%) & 8476 (6.0\%) & 12789 (9.4\%) & 8234 (5.2\%) & 92728 (10.8\%) & 117664 (9.7\%) \\ 
    Unknown & 1373 (2.0\%) & 3328 (2.4\%) & 3583 (2.6\%) & 3781 (2.4\%) & 72671 (8.4\%) & 82143 (6.7\%) \\ 
  Age (years) &  &  &  &  &  &  \\ 
    Mean (SD) & 72.2 (12.6) & 59.3 (18.0) & 64.6 (13.7) & 64.6 (15.1) & 49.9 (17.7) & 53.5 (18.1) \\ 
    Median [Min, Max] & 73.7 [18.2, 99.0] & 62.3 [18.1, 99.0] & 66.1 [18.1, 98.7] & 66.9 [18.1, 98.9] & 49.9 [18.1, 98.9] & 54.8 [18.1, 99.0] \\ 
  Age bracket &  &  &  &  &  &  \\ 
    [18,20) & 25 (0.0\%) & 1875 (1.3\%) & 158 (0.1\%) & 497 (0.3\%) & 19013 (2.2\%) & 21407 (1.8\%) \\ 
    [20,25) & 107 (0.2\%) & 4960 (3.5\%) & 677 (0.5\%) & 1671 (1.1\%) & 54740 (6.3\%) & 61586 (5.1\%) \\ 
    [25,30) & 232 (0.3\%) & 5160 (3.7\%) & 1199 (0.9\%) & 2286 (1.4\%) & 64594 (7.5\%) & 72565 (6.0\%) \\ 
    [30,35) & 423 (0.6\%) & 6100 (4.3\%) & 1996 (1.5\%) & 3427 (2.2\%) & 73725 (8.5\%) & 84258 (6.9\%) \\ 
    [35,45) & 1681 (2.4\%) & 14133 (10.1\%) & 8213 (6.0\%) & 10751 (6.8\%) & 148226 (17.2\%) & 177581 (14.6\%) \\ 
    [45,55) & 4122 (6.0\%) & 18884 (13.4\%) & 18320 (13.5\%) & 18920 (12.0\%) & 148768 (17.3\%) & 196359 (16.1\%) \\ 
    [55,65) & 9988 (14.5\%) & 27308 (19.4\%) & 32655 (24.0\%) & 32910 (20.8\%) & 151766 (17.6\%) & 227478 (18.7\%) \\ 
    [65,75) & 21325 (31.0\%) & 33873 (24.1\%) & 41599 (30.6\%) & 47302 (29.9\%) & 132786 (15.4\%) & 229930 (18.9\%) \\ 
    [75,85) & 21206 (30.8\%) & 21246 (15.1\%) & 24571 (18.1\%) & 30678 (19.4\%) & 54429 (6.3\%) & 114080 (9.4\%) \\ 
    [85,Inf) & 9787 (14.2\%) & 6896 (4.9\%) & 6527 (4.8\%) & 9574 (6.1\%) & 14288 (1.7\%) & 33386 (2.7\%) \\ 
  Breakthrough COVID-19 infection &  &  &  &  &  &  \\ 
    Breakthrough COVID & 1965 (2.9\%) & 4800 (3.4\%) & 3740 (2.8\%) & 4553 (2.9\%) & 12594 (1.5\%) & 22459 (1.8\%) \\ 
    No breakthrough & 66931 (97.1\%) & 135635 (96.6\%) & 132175 (97.2\%) & 153463 (97.1\%) & 849741 (98.5\%) & 1196171 (98.2\%) \\ 
  Hospitalization following breakthrough &  &  &  &  &  &  \\ 
    Hospitalized & 863 (1.3\%) & 1248 (0.9\%) & 1065 (0.8\%) & 1274 (0.8\%) & 1018 (0.1\%) & 3352 (0.3\%) \\ 
    Not hospitalized & 68033 (98.7\%) & 139187 (99.1\%) & 134850 (99.2\%) & 156742 (99.2\%) & 861317 (99.9\%) & 1215278 (99.7\%) \\ 
   \hline
\end{tabular}
\caption{Overall summary statistics of our analyzed population of patients who have completed there primary COVID-19 vaccination sequence.} 
\label{tab:table_1}
\end{table}
